Microbot Medical (NASDAQ:MBOT) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

Microbot Medical Inc. (NASDAQ:MBOT)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.99 and traded as high as $1.02. Microbot Medical shares last traded at $1.01, with a volume of 116,758 shares traded.

Microbot Medical Trading Up 0.1 %

The company has a market cap of $16.48 million, a price-to-earnings ratio of -1.22 and a beta of 1.62. The company’s 50 day moving average price is $0.97 and its 200 day moving average price is $0.99.

Institutional Investors Weigh In On Microbot Medical

An institutional investor recently bought a new position in Microbot Medical stock. Thoroughbred Financial Services LLC bought a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned approximately 0.33% of Microbot Medical at the end of the most recent quarter. 16.30% of the stock is owned by hedge funds and other institutional investors.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.